Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Grimm

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2007
Combinatorial RNAi: a winning strategy for the race against evolving targets?Dirk Grimm, Mark A Kay
Biotechnology Journal|September 25, 2020
Production, Processing, and Characterization of Synthetic AAV Gene Therapy VectorsJihad El Andari, Dirk Grimm
The Journal of Clinical Investigation|December 7, 2007
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Dirk Grimm, Mark A Kay
Hematology. American Society of Hematology. Education Program|November 21, 2007
RNAi and gene therapy: a mutual attractionDirk Grimm, Mark A Kay
Molecular Therapy. Nucleic Acids|May 4, 2022
Right on target: The next class of efficient, safe, and specific RNAi triggersJonas Becker, Nico Fischer, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2020
Lab-Scale Production of Recombinant Adeno-Associated Viruses (AAV) for Expression of Optogenetic ElementsJanina Haar, Chiara Krämer, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) VectorsJulia Fakhiri, Manuela Nickl, Dirk Grimm
Progress in Molecular Biology and Translational Science|August 18, 2011
When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapyStefan Mockenhaupt, Nina Schürmann, Dirk Grimm
Pathogens (Basel, Switzerland)|July 27, 2022
Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine LearningJonas Becker, Julia Fakhiri, Dirk Grimm
Molecular Therapy. Methods & Clinical Development|October 10, 2022
Determination of AAV properties by single amino acids: Go(o)d is in the detailsOlena Maiakovska, Conradin Baumgartl, Dirk Grimm
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2007
Combinatorial RNAi: a winning strategy for the race against evolving targets?Dirk Grimm, Mark A Kay
Biotechnology Journal|September 25, 2020
Production, Processing, and Characterization of Synthetic AAV Gene Therapy VectorsJihad El Andari, Dirk Grimm
The Journal of Clinical Investigation|December 7, 2007
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Dirk Grimm, Mark A Kay
Hematology. American Society of Hematology. Education Program|November 21, 2007
RNAi and gene therapy: a mutual attractionDirk Grimm, Mark A Kay
Molecular Therapy. Nucleic Acids|May 4, 2022
Right on target: The next class of efficient, safe, and specific RNAi triggersJonas Becker, Nico Fischer, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2020
Lab-Scale Production of Recombinant Adeno-Associated Viruses (AAV) for Expression of Optogenetic ElementsJanina Haar, Chiara Krämer, Dirk Grimm
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) VectorsJulia Fakhiri, Manuela Nickl, Dirk Grimm
Progress in Molecular Biology and Translational Science|August 18, 2011
When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapyStefan Mockenhaupt, Nina Schürmann, Dirk Grimm
Pathogens (Basel, Switzerland)|July 27, 2022
Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine LearningJonas Becker, Julia Fakhiri, Dirk Grimm
Molecular Therapy. Methods & Clinical Development|October 10, 2022
Determination of AAV properties by single amino acids: Go(o)d is in the detailsOlena Maiakovska, Conradin Baumgartl, Dirk Grimm
Pageof 16